Okines AFC - Search Results

1

Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.

Cunningham N, Shepherd S, Mohammed K, Lee KA, Allen M, Johnston S, Kipps E, McGrath S, Noble J, Parton M, Ring A, Turner NC, Okines AFC. Cunningham N, et al. Among authors: okines afc. Breast Cancer Res Treat. 2022 Oct;195(3):333-340. doi: 10.1007/s10549-022-06703-3. Epub 2022 Aug 17. Breast Cancer Res Treat. 2022. PMID: 35976513 Free PMC article.

2

Capecitabine in advanced gastric cancer.

Okines A, Chau I, Cunningham D. Okines A, et al. Expert Opin Pharmacother. 2007 Nov;8(16):2851-61. doi: 10.1517/14656566.8.16.2851. Expert Opin Pharmacother. 2007. PMID: 17956204 Review.

3

Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?

Okines A, Cunningham D. Okines A, et al. Eur J Cancer. 2009 Sep;45(14):2452-61. doi: 10.1016/j.ejca.2009.06.028. Epub 2009 Jul 28. Eur J Cancer. 2009. PMID: 19643598

4

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.

Hawkes E, Okines AF, Papamichael D, Rao S, Ashley S, Charalambous H, Koukouma A, Chau I, Cunningham D. Hawkes E, et al. Eur J Cancer. 2011 May;47(8):1146-51. doi: 10.1016/j.ejca.2010.12.021. Epub 2011 Jan 25. Eur J Cancer. 2011. PMID: 21269822

5

Current and Future Therapies for Advanced Gastric Cancer.

Davidson M, Okines AF, Starling N. Davidson M, et al. Clin Colorectal Cancer. 2015 Dec;14(4):239-50. doi: 10.1016/j.clcc.2015.05.013. Epub 2015 Jun 6. Clin Colorectal Cancer. 2015. PMID: 26524924 Review.

6

T-DM1 in the Neo-Adjuvant Treatment of HER2-Positive Breast Cancer: Impact of the KRISTINE (TRIO-021) Trial.

Okines AF. Okines AF. Rev Recent Clin Trials. 2017;12(3):216-222. doi: 10.2174/1574887112666170529094911. Rev Recent Clin Trials. 2017. PMID: 28552047 Review.

7

De-escalating and escalating systemic therapy of early breast cancer.

Smith IE, Okines AFC. Smith IE, et al. Among authors: okines afc. Breast. 2017 Aug;34 Suppl 1:S5-S9. doi: 10.1016/j.breast.2017.06.019. Epub 2017 Jul 8. Breast. 2017. PMID: 28694014 No abstract available.

8

Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.

Okines A, Irfan T, Khabra K, Smith I, O'Brien M, Parton M, Noble J, Stanway S, Somaiah N, Ring A, Johnston S, Turner N. Okines A, et al. Breast J. 2018 May;24(3):253-259. doi: 10.1111/tbj.12906. Epub 2017 Aug 22. Breast J. 2018. PMID: 28833867

9

Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.

Kingston B, Kayhanian H, Brooks C, Cox N, Chaabouni N, Redana S, Kalaitzaki E, Smith I, O'Brien M, Johnston S, Parton M, Noble J, Stanway S, Ring A, Turner N, Okines A. Kingston B, et al. Breast. 2017 Dec;36:54-59. doi: 10.1016/j.breast.2017.07.015. Epub 2017 Sep 29. Breast. 2017. PMID: 28968585

10

To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity.

Ameratunga M, Kipps E, Okines AFC, Lopez JS. Ameratunga M, et al. Among authors: okines afc. Clin Cancer Res. 2019 Jan 1;25(1):21-28. doi: 10.1158/1078-0432.CCR-18-1999. Epub 2018 Sep 17. Clin Cancer Res. 2019. PMID: 30224338 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters